Lorenz Katrin

Course of serum autoantibodies in patients after acute angle-closure glaucoma attack.

With this autoantibodies profiling approach, we were able to detect autoimmune reactivities in sera of patients without former indication for glaucomatous damage after rise of IOP due to AACG attack.

A European Study of the Performance and Safety of MINIject in Patients With Medically Uncontrolled Open-angle Glaucoma (STAR-II).

Ab-interno supraciliary surgical implantation using MINIject DO627 in a stand-alone procedure significantly lowers IOP by 40% at the 6-month follow-up, while reducing the need for IOP-lowering medication.

Three-Year Results of Hydrus Microstent with Phacoemulsification.

Mid-term real world outcomes of the HydrusMicrostent in open angle glaucoma.

This study underlines the effectiveness and the safety of the HydrusMicrostent in an elective setting, but it also demonstrates certain limits and risk factors of this procedure.

A Randomized Trial of a Schlemm's Canal Microstent with Phacoemulsification for Reducing Intraocular Pressure in Open-Angle Glaucoma.

Intraocular pressure was clinically and statistically significantly lower at 2 years in the Hydrus plus CS group compared with the CS alone group, with no differences in safety.